The FDA has cleared Teleflex to market its ARROW UltraQuik needles for use by clinicians when performing single-injection peripheral nerve blocks. The needle tips come with five grooved rings to help clinicians identify them better with an ultrasound.
Teleflex's peripheral nerve block needles land 510(k) clearance
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan
|Vice President of Finance||
Urban Health Plan, Inc.
|Director of Payor/Provider Contracting||
U.S. Medical Management